<DOC>
	<DOCNO>NCT01078051</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness drug-eluting stent implantation compare optimal medical treatment patient chronic total occlusion .</brief_summary>
	<brief_title>Drug-Eluting Stent Implantation Versus Optimal Medical Treatment Patients With Chronic Total Occlusion ( DECISION-CTO )</brief_title>
	<detailed_description>Prospective , two arm , randomize multi-center trial Asian-pacific region . Following angiography , patient chronic total occlusion ( 3 month ) document myocardial ischemia symptom angina , eligible stenting without exclusion criterion randomize 1:1 : ) drug-eluting stent vs. b ) optimal medical treatment . All patient follow least 3 year .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Clinical 1 . Patients angina silent ischemia document ischemia 2 . Patients eligible intracoronary stenting 3 . Age &gt; 18 year Angiographic 1 . De novo lesion CTO 2 . Reference vessel size 2.5 mm visual estimation 3 . At least one CTO lesion locate proximal mid epicardial coronary artery . ( If patient two CTO lesion , one CTO lesion locate proximal mid epicardial coronary artery ) CTO definition : TIMI flow 0 estimate duration 3 month The duration occlusion determine interval last episode acute coronary syndrome , In patient without history acute coronary syndrome , first episode effort angina consistent location occlusion 1 . Angiographically defined total occlusion 3 month 2 . If definite symptom total occlusion , two experience operator decide CTO consideration angiographical morphology ( degree calcification , bridge collateral , nontapered stump , angiographic filling collateral ) 1 . History bleed diathesis coagulopathy 2 . Pregnant state 3 . Three vessel CTO 4 . Known hypersensitivity contraindication contrast agent heparin 5 . STelevation acute myocardial infarction require primary stenting 6 . Characteristics lesion 1 ) Left main disease 2 ) Instent restenosis 3 ) Graft vessel 4 ) Distal epicardial coronary artery CTO lesions 7 . Hematological disease 8 . Hepatic dysfunction , liver enzyme ( ALT AST ) elevation 3 time normal 9 . Renal dysfunction , creatinine 2.0 10 . Contraindication aspirin , clopidogrel commercial antiplatelet agent 11 . Left ventricular ejection fraction 12 . Patients actively participate another drug device investigational study , complete primary endpoint followup period . 13 . Noncardiac comorbid condition present limited life expectancy may result protocol noncompliance ( per site investigator 's medical judgment ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>chronic total occlusion</keyword>
	<keyword>stent</keyword>
	<keyword>medical therapy</keyword>
</DOC>